Aids vaccines: Back to 'plan A'

被引：15
作者：
Check, E
机构：
来源：
NATURE | 2003年 / 423卷 / 6943期
关键词：
D O I：
10.1038/423912a
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Vaccines
引用
收藏
页码：912 / 914
页数：3
相关论文
共 10 条
  • [1] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    [J]. NATURE, 1990, 345 (6276) : 622 - 625
  • [2] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY
    BURTON, DR
    PYATI, J
    KODURI, R
    SHARP, SJ
    THORNTON, GB
    PARREN, PWHI
    SAWYER, LSW
    HENDRY, RM
    DUNLOP, N
    NARA, PL
    LAMACCHIA, M
    GARRATTY, E
    STIEHM, ER
    BRYSON, YJ
    CAO, YZ
    MOORE, JP
    HO, DD
    BARBAS, CF
    [J]. SCIENCE, 1994, 266 (5187) : 1024 - 1027
  • [3] Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization
    Chakrabarti, BK
    Kong, W
    Wu, B
    Yang, ZY
    Friborg, J
    Ling, X
    King, SR
    Montefiori, DC
    Nabel, GJ
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (11) : 5357 - 5368
  • [4] NEUTRALIZATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES BY THE BROADLY REACTIVE ANTI-V3 MONOCLONAL-ANTIBODY, 447-52D
    CONLEY, AJ
    GORNY, MK
    KESSLER, JA
    BOOTS, LJ
    OSSORIOCASTRO, M
    KOENIG, S
    LINEBERGER, DW
    EMINI, EA
    WILLIAMS, C
    ZOLLAPAZNER, S
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (11) : 6994 - 7000
  • [5] Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression
    Huang, Y
    Kong, WP
    Nabel, GJ
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (10) : 4947 - 4951
  • [6] Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1
    Mascola, JR
    Snyder, SW
    Weislow, OS
    Belay, SM
    Belshe, RB
    Schwartz, DH
    Clements, ML
    Dolin, R
    Graham, BS
    Gorse, GJ
    Keefer, MC
    McElrath, MJ
    Walker, MC
    Wagner, KF
    McNeil, JG
    McCutchan, FE
    Burke, DS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) : 340 - 348
  • [7] Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design
    Pantophlet, R
    Wilson, IA
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (10) : 5889 - 5901
  • [8] Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design
    Saphire, EO
    Parren, PWHI
    Pantophlet, R
    Zwick, MB
    Morris, GM
    Rudd, PM
    Dwek, RA
    Stanfield, RL
    Burton, DR
    Wilson, IA
    [J]. SCIENCE, 2001, 293 (5532) : 1155 - 1159
  • [9] Alternative conformations of HIV-1V3 loops mimic β hairpins in chemokines, suggesting a mechanism for coreceptor selectivity
    Sharon, M
    Kessler, N
    Levy, R
    Zolla-Pazner, S
    Görlach, M
    Anglister, J
    [J]. STRUCTURE, 2003, 11 (02) : 225 - 236
  • [10] Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    Trkola, A
    Purtscher, M
    Muster, T
    Ballaun, C
    Buchacher, A
    Sullivan, N
    Srinivasan, K
    Sodroski, J
    Moore, JP
    Katinger, H
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 1100 - 1108
1